Beacon Pharmaceuticals has promoted its Executive Vice President Mahmudul Haque Pallab to Director, Sales and Marketing OBP, recognising his leadership role and strategic contribution to the company’s commercial growth.
In a press statement, Beacon Pharmaceuticals said the promotion reflects Pallab’s “outstanding leadership, strategic vision and significant contributions” to sustaining the company’s market position.
He has played a central role in strengthening commercial operations, expanding market reach and improving performance across major therapeutic segments, it added.
During his tenure as senior vice president, Pallab led multiple initiatives that helped scale Beacon’s presence in oncology, hepatitis, rheumatic arthritis and diabetic care.
The company said his people-focused leadership approach and emphasis on ethical marketing supported its wider mission of delivering quality healthcare solutions nationwide.
Beacon Pharmaceuticals also said the company continues to contribute significantly to national healthcare by improving access to innovative and affordable treatments, adding that its work in critical disease areas has benefited millions of patients across Bangladesh.
Following his promotion, Mahmudul Haque Pallab will lead new strategic initiatives aimed at strengthening Beacon’s leadership position and supporting long-term sustainable growth, the statement said.
Beacon Pharmaceuticals, a homegrown publicly traded pharmaceutical company, has earned an international reputation for producing oncology drugs at affordable prices.
